<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 AND RULE 13a-17
OR 15d-17 THEREUNDER
Physician Reliance Network, Inc.
-------------------------------------------------
(Exact name of issuer as specified in charter)
8115 Preston Road, Suite 300, Dallas, Texas 75225
-------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code (214) 692-3800
----------------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
1. Title of security: Common Stock
----------------------------------------------------------
2. Number of shares outstanding before the change: 23,656,485
----------------------------
3. Number of shares outstanding after the change: 47,312,970
-----------------------------
4. Effective date of change: May 31, 1996 (record date); June 10, 1996
--------------------------------------------------
(payment date)
--------------------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution,
stock split, reverse split, acquisition of stock for treasury, etc.):
Stock Split
------------------------------------------------------------------
Give brief description of transaction: 2-for-1 split of the Company's
---------------------------------
Common Stock
------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change
--------------------------------------------------------
2. Name after change
-----------------------------------------------------------
3. Effective date of charter amendment changing name
---------------------------
4. Date of shareholder approval of change, if required
-------------------------
Date: June 4, 1996 /s/ Randall D. Kurtz
---------------------- ------------------------------------
Randall D. Kurtz
Executive Vice President and
Chief Financial Officer
